SC
Stempoint Capital Portfolio holdings
AUM
$311M
This Quarter Return
+35.12%
1 Year Return
+15.22%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$374M
AUM Growth
+$374M
(+7.5%)
Cap. Flow
-$20.9M
Cap. Flow
% of AUM
-5.59%
Top 10 Holdings %
Top 10 Hldgs %
57.86%
Holding
84
New
17
Increased
16
Reduced
11
Closed
27
Top Buys
| 1 |
Crinetics Pharmaceuticals
CRNX
|
$17.3M |
| 2 |
AUTL
Autolus Therapeutics
AUTL
|
$16M |
| 3 |
Roivant Sciences
ROIV
|
$14.6M |
| 4 |
Immunovant
IMVT
|
$9.86M |
| 5 |
Cabaletta Bio
CABA
|
$9.44M |
Top Sells
| 1 |
Merus
MRUS
|
$12.1M |
| 2 |
Arcellx
ACLX
|
$12.1M |
| 3 |
Spyre Therapeutics
SYRE
|
$12M |
| 4 |
Protagonist Therapeutics
PTGX
|
$11.8M |
| 5 |
BridgeBio Pharma
BBIO
|
$10.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Shattuck Labs
STTK
$47M
| – | – |
-147,752
| Closed | -$1.05M |
|
77
Teva Pharmaceuticals
TEVA
$21.1B
| – | – |
0
| – | – |
|
78
United Therapeutics
UTHR
$13.8B
| – | – |
0
| – | – |
|
79
Vera Therapeutics
VERA
$1.38B
| – | – |
0
| – | – |
|
80
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – |
0
| – | – |
|
|
MOR
81
DELISTED
MorphoSys AG American Depositary Shares
MOR
| – | – |
0
| – | – |
|
|
ALPN
82
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| – | – |
-246,178
| Closed | -$4.69M |
|
|
CBAY
83
DELISTED
Cymabay Therapeutics
CBAY
| – | – |
-182,258
| Closed | -$4.3M |
|
|
AMAM
84
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
| – | – |
-126,101
| Closed | -$1.8M |
|